ALIVISATOS TALKS SUSTAINABILITY AT TOWN HALL PAGE 5
JANUARY 12, 2022 FIRST WEEK VOL. 134, ISSUE 10
CPD Investigates Recent Woodlawn Fires for Arson By ERIC FANG | Senior News Reporter The Chicago Police Department (CPD) is currently investigating two recent fires that occurred in Woodlawn Residential Commons at 3 a.m. on Tuesday, December 7, 2021 for aggravated arson. The investigation began the day of the fires and is currently ongoing. A University of Chicago Police Department (UCPD) incident report said that the fires occurred in second- and third-floor community bathrooms in Woodlawn Residential Commons. The report also confirmed that while there was property damage, no injuries were reported. A separate CPD report indicated that no arrest was made in connection with the fires. According to a December 7 email sent by Heath Rossner, the Interim Executive Direc-
The entrance to Woodlawn Commons. COURTESY OF EMELINE WRIGHT
tor of Housing and Residence Life, to students living in Woodlawn Residential Commons, the University is cooperating with UCPD, CPD, and the Chicago Fire Department (CFD) to investigate the fires. On the morning of the fires, fire alarms went off at 3:46 a.m., and Woodlawn Residential Commons was evacuated. Residents returned to their dormitories at 4:02 a.m., after CFD and facility services had responded to the alarm and determined the building was safe to enter. Aggravated arson is typically defined as a fire intentionally set within an occupied building. In Illinois, it is a Class X felony, which is punishable by between six and 30 years in prison.
UChicago Professor Pleads Not Guilty to Federal Charges of Insider Trading By YIWEN LU | News Editor Daniel Catenacci, an associate professor of medicine in the Biological Sciences Division, was charged with insider trading on Monday, December 20, 2021. The charge alleged that he used confidential information gained through his position at the University to make over $134,000 in illegal profits. He pled not guilty during a remote arraignment hearing on Tuesday, January 4. Catenacci is an oncologist who served as the director of the gastrointestinal oncology program at the University. The U.S. Attorney’s Office in Chicago filed a criminal charge on December 20, 2021, alleging that Catenacci had purchased shares of a biotechnology company with prior knowledge of then-unannounced positive trial results, and had sold the shares shortly after the an-
nouncement. According to Law 360, the biotechnology company involved was Five Prime Therapeutics, Inc. (“Five Prime”), a clinical-stage biotechnology company based in South San Francisco, California. Through his role at the University, Catenacci worked as a clinical investigator on Five Prime’s experimental cancer drug, bemarituzumab. On November 9, 2020, Catenacci received an email from Five Prime’s chief medical officer notifying him that bemarituzamb had passed its Phase 2 clinical trial and that U.S. securities law prohibited him from selling or buying stocks on the basis of this information, according to the charges. The following morning, Catenacci bought 8,743 shares of Five Prime’s stock. Five Prime pub-
ARTS: Marvel’s Eternals - Too much of a good thing?
VIEWPOINTS: Rawan Abbas argues that The Maroon must engage in activism
PAGE 9
UChicago Medicine. COURTESY OF UCHICAGO MEDICINE licly announced the results of the trial after the market closed that same day. Five Prime’s stock increased by more
than 300 percent on November 11, 2020— the day after they announced the trial CONTINUED ON PG. 2
SPORTS: Meet the B-J residents who trained for Chicago’s half-marathon together.
PAGE ?
Like our Facebook page at facebook.com/chicagomaroon and follow @chicagomaroon on Instagram and Twitter to get the latest updates on campus news.
PAGE ? chicagomaroon.com